Jerry Morris, MD, PhD, A(ACHI)
University of California San Diego
The Organ Procurement and Transplantation Network (OPTN) Histocompatibility Committee applies evolving science and technology in transplant immunology to develop, implement, and inform OPTN bylaws, policies, and clinical guidance for organ donation and transplantation. At this year's Combined Directors' and Technologists' Forum, OPTN Histocompatibility Chair Dr. Gerald Morris will provide an important update on behalf of the committee.